VC  BioInnovation

     Office Locations:

1 Broadway, 14th Floor
Cambridge, MA 02142
Phone: 617-276-5578



  • Early
  • Seed



  • Life Sciences & Healthcare
  • Medical Device



    BioInnovation is an early stage life sciences investment and consulting firm. The firm makes seed investments, acts as institutional co-founders, providing strategic and operational services. BioInnovation, along with two other partners (Cambridge BioLabs and the Cambridge Innovation Center) has launched a novel state-of-the-art shared laboratory space at 700 Main St in Kendall Sq. Named LabCentral, this new concept for entrepreneurs who need lab space is a non-profit funded in part with a grant from the Mass Life Sciences Center and MIT Investment Mgmt Co. Through the firm's affiliate contract research organization, Cambridge Biolabs, BioInnovation provides fully equipped Class II laboratory space. This Class II laboratory is outfitted for standard wet-bench molecular and cell biology, has shared infrastructure and administrative support and is available for approx $5,000/month. BioInnovation invests in a limited number of early stage life science companies per year.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Chris Carlin VP Operations and Chief Compliance Officer
    Douglas Crawford PhD Senior Advisor
    Johannes Fruehauf MD, PhD General Partner
    Peter D. Parker Founder and Managing General Partner
    Susie Harborth Co-Founder and CFO


    Recent Funding Events (trailing 12 months):







      Pandion Therapeutics



      Series A


    Portfolio companies include:

      Avexegen Therapeutics
        web link


      Pandion Therapeutics
        web link

      PanTher Therapeutics
        web link

      Sentien Biotechnologies
        web link

      Vaxess Technologies
        web link


    Recent News:

      There is no recent news for BioInnovation.